| Dr Thomas Frank Mazzoni, DO | |
|
485 Route 1 S, Building B Suite 350, Iselin, NJ 08830-0883 | |
| (732) 549-3934 | |
| (732) 549-7250 |
| Full Name | Dr Thomas Frank Mazzoni |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 22 Years |
| Location | 485 Route 1 S, Building B Suite 350, Iselin, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629192463 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jfk Medical Center | Edison, NJ | Hospital |
| Newark Beth Israel Medical Center | Newark, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ent And Allergy Associates Llp | 0749193662 | 368 |
News Archive
A Vancouver-led research initiative to prevent deaths of moms and babies got a boost recently with a new $1.5-million grant from the Bill & Melinda Gates Foundation. The grant will expand efforts to improve diagnosis and care for pregnant women with pre-eclampsia.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, announces today that it has granted an aggregate of 175,000 stock options at an exercise price of $0.15 per common share, to the President & CEO of the Company.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Scientists have developed a new kind of tiny motor - which they term a "microrocket" - that can propel itself through acidic environments, such as the human stomach, without any external energy source, opening the way to a variety of medical and industrial applications.
Administrative hospital data can successfully quantify the incidence of healthcare-associated urinary tract infection, indicating the data's potential use for risk monitoring and surveillance of this frequent occurrence, show systematic review results.
› Verified 7 days ago
| Entity Name | West Scharf Conte Bastianelli Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972549780 PECOS PAC ID: 5092799452 Enrollment ID: O20040615000517 |
News Archive
A Vancouver-led research initiative to prevent deaths of moms and babies got a boost recently with a new $1.5-million grant from the Bill & Melinda Gates Foundation. The grant will expand efforts to improve diagnosis and care for pregnant women with pre-eclampsia.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, announces today that it has granted an aggregate of 175,000 stock options at an exercise price of $0.15 per common share, to the President & CEO of the Company.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Scientists have developed a new kind of tiny motor - which they term a "microrocket" - that can propel itself through acidic environments, such as the human stomach, without any external energy source, opening the way to a variety of medical and industrial applications.
Administrative hospital data can successfully quantify the incidence of healthcare-associated urinary tract infection, indicating the data's potential use for risk monitoring and surveillance of this frequent occurrence, show systematic review results.
› Verified 7 days ago
| Entity Name | Ent And Allergy Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376598326 PECOS PAC ID: 0749193662 Enrollment ID: O20041122001007 |
News Archive
A Vancouver-led research initiative to prevent deaths of moms and babies got a boost recently with a new $1.5-million grant from the Bill & Melinda Gates Foundation. The grant will expand efforts to improve diagnosis and care for pregnant women with pre-eclampsia.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, announces today that it has granted an aggregate of 175,000 stock options at an exercise price of $0.15 per common share, to the President & CEO of the Company.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Scientists have developed a new kind of tiny motor - which they term a "microrocket" - that can propel itself through acidic environments, such as the human stomach, without any external energy source, opening the way to a variety of medical and industrial applications.
Administrative hospital data can successfully quantify the incidence of healthcare-associated urinary tract infection, indicating the data's potential use for risk monitoring and surveillance of this frequent occurrence, show systematic review results.
› Verified 7 days ago
| Entity Name | Ent Sinus And Sleep Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902575129 PECOS PAC ID: 1456741644 Enrollment ID: O20211202000043 |
News Archive
A Vancouver-led research initiative to prevent deaths of moms and babies got a boost recently with a new $1.5-million grant from the Bill & Melinda Gates Foundation. The grant will expand efforts to improve diagnosis and care for pregnant women with pre-eclampsia.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, announces today that it has granted an aggregate of 175,000 stock options at an exercise price of $0.15 per common share, to the President & CEO of the Company.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Scientists have developed a new kind of tiny motor - which they term a "microrocket" - that can propel itself through acidic environments, such as the human stomach, without any external energy source, opening the way to a variety of medical and industrial applications.
Administrative hospital data can successfully quantify the incidence of healthcare-associated urinary tract infection, indicating the data's potential use for risk monitoring and surveillance of this frequent occurrence, show systematic review results.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Frank Mazzoni, DO 660 White Plains Rd Ste 400, Tarrytown, NY 10591-5107 Ph: (914) 984-2546 | Dr Thomas Frank Mazzoni, DO 485 Route 1 S, Building B Suite 350, Iselin, NJ 08830-0883 Ph: (732) 549-3934 |
News Archive
A Vancouver-led research initiative to prevent deaths of moms and babies got a boost recently with a new $1.5-million grant from the Bill & Melinda Gates Foundation. The grant will expand efforts to improve diagnosis and care for pregnant women with pre-eclampsia.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, announces today that it has granted an aggregate of 175,000 stock options at an exercise price of $0.15 per common share, to the President & CEO of the Company.
AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.
Scientists have developed a new kind of tiny motor - which they term a "microrocket" - that can propel itself through acidic environments, such as the human stomach, without any external energy source, opening the way to a variety of medical and industrial applications.
Administrative hospital data can successfully quantify the incidence of healthcare-associated urinary tract infection, indicating the data's potential use for risk monitoring and surveillance of this frequent occurrence, show systematic review results.
› Verified 7 days ago
Stuart A Ort, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 485 Route 1 South - Suite 350, Bldg. B, 3rd Floor, Iselin, NJ 17033 Phone: 732-549-4120 Fax: 732-549-7250 | |
Dr. Sayani Niyogi, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 485 Route 1 S Bldg B Ste 350, Iselin, NJ 08830 Phone: 732-549-3934 Fax: 732-549-7250 | |
Dr. Robert D Huang, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 485 Route 1 S, Bldg B, Suite 350, Iselin, NJ 08830 Phone: 732-549-3934 Fax: 732-549-7250 | |
Vishvesh Mehta, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 485 Route 1 S, Bldg. B, Suite 350, Iselin, NJ 08830 Phone: 732-549-3934 Fax: 732-549-7250 |